Medtronic, IBM Watson Health Partner To Roll Out AI App For Diabetes Management

Medtronic and IBM Watson recently partnered to roll out a new artificial intelligence (AI) app for diabetes management. The app, Sugar.IQ, is currently available for consumers who are using Guardian Connect, Medtronic’s continuous glucose monitoring system.

Specifically, Sugar.IQ utilizes AI and analytics to analyze the impact different foods, daily routines, and insulin dosages have on glucose levels. The two organizations anticipate that the app will help to equip individuals with diabetes with the guidance they need to best manage their glucose levels. According to research, Sugar.IQ users spent 36 more minutes per day at healthy glucose . . .